Siddik Sarkar
Title
Cited by
Cited by
Year
Targeting Mcl-1 for the therapy of cancer
BA Quinn, R Dash, B Azab, S Sarkar, SK Das, S Kumar, RA Oyesanya, ...
Expert opinion on investigational drugs 20 (10), 1397-1411, 2011
2122011
Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water
SM Mandal, S Dey, M Mandal, S Sarkar, S Maria-Neto, OL Franco
Peptides 30 (4), 633-637, 2009
1352009
Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer
S Rajput, BNP Kumar, S Sarkar, S Das, B Azab, PK Santhekadur, SK Das, ...
PLoS One 8 (4), e61342, 2013
1112013
ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells
S Sarkar, A Mazumdar, R Dash, D Sarkar, PB Fisher, M Mandal
Cancer biology & therapy 9 (8), 592-603, 2010
892010
Structural identification and cytotoxic activity of a polysaccharide from the fruits of Lagenaria siceraria (Lau)
K Ghosh, K Chandra, AK Ojha, S Sarkar, SS Islam
Carbohydrate research 344 (5), 693-698, 2009
602009
Crosslinking of gelatin-based drug carriers by genipin induces changes in drug kinetic profiles in vitro
G Thakur, A Mitra, D Rousseau, A Basak, S Sarkar, K Pal
Journal of Materials Science: Materials in Medicine 22 (1), 115-123, 2011
542011
Biomarkers for the diagnosis of thyroid cancer
K Sethi, S Sarkar, S Das, B Mohanty, M Mandal
J Exp Ther Oncol 8 (4), 341-52, 2010
532010
Overcoming Akt induced therapeutic resistance in breast cancer through siRNA and thymoquinone encapsulated multilamellar gold niosomes
S Rajput, N Puvvada, BNP Kumar, S Sarkar, S Konar, R Bharti, G Dey, ...
Molecular pharmaceutics 12 (12), 4214-4225, 2015
522015
Enzyme/Prodrug Systems for Cancer Gene Therapy
OM Malekshah, X Chen, A Nomani, S Sarkar, A Hatefi
Current pharmacology reports 2 (6), 299-308, 2016
502016
Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression
N Puvvada, S Rajput, BNP Kumar, S Sarkar, S Konar, KR Brunt, RR Rao, ...
Scientific reports 5, 11760, 2015
502015
Novel mechanism of MDA-7/IL-24 cancer-specific apoptosis through SARI induction
R Dash, P Bhoopathi, SK Das, S Sarkar, L Emdad, S Dasgupta, D Sarkar, ...
Cancer research 74 (2), 563-574, 2014
502014
Enhanced delivery of mda‐7/IL‐24 using a serotype chimeric adenovirus (Ad. 5/3) in combination with the apogossypol derivative BI‐97C1 (Sabutoclax) improves therapeutic …
B Azab, R Dash, SK Das, SK Bhutia, XN Shen, BA Quinn, S Sarkar, ...
Journal of cellular physiology 227 (5), 2145-2153, 2012
482012
Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic
R Dash, B Azab, XN Shen, UK Sokhi, S Sarkar, Z Su, XY Wang, ...
Discovery medicine 11 (56), 46, 2011
452011
AEG-1 Promoter–Mediated Imaging of Prostate Cancer
A Bhatnagar, Y Wang, RC Mease, M Gabrielson, P Sysa, I Minn, G Green, ...
Cancer research 74 (20), 5772-5781, 2014
352014
ZD6474 enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma cells
S Sarkar, A Mazumdar, R Dash, D Sarkar, PB Fisher, M Mandal
Journal of cellular physiology 226 (2), 375-384, 2011
342011
Cancer terminator viruses and approaches for enhancing therapeutic outcomes
SK Das, S Sarkar, R Dash, P Dent, XY Wang, D Sarkar, PB Fisher
Advances in cancer research 115, 1-38, 2012
322012
Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma
K Sethi, S Sarkar, S Das, S Rajput, A Mazumder, B Roy, S Patra, ...
J Exp Ther Oncol 9 (3), 187-199, 2011
312011
Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic
S Sarkar, BA Quinn, XN Shen, R Dash, SK Das, L Emdad, AL Klibanov, ...
Oncotarget 6 (13), 10712, 2015
262015
Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer terminator virus
S Sarkar, B Azab, BA Quinn, X Shen, P Dent, AL Klibanov, L Emdad, ...
Current molecular medicine 14 (1), 125-140, 2014
242014
Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules
M Hedvat, L Emdad, S K Das, K Kim, S Dasgupta, S Thomas, B Hu, S Zhu, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2012
242012
The system can't perform the operation now. Try again later.
Articles 1–20